Asthma

Investigators assessing the link from CO to pneumonia risk—and the benefit of biomass-fueled cookstoves in reducing them—find it is not very distinct.

ALA chief medical officer Al Rizzo, MD, discusses plans to kickstart vaccine research and public health preventive measures.

Clinical investigator and allergist Jonathan Corren, MD, shares insight on the TSLP inhibitor.

The Proventil HFA generic approval comes at a time of greater inhaler therapy demand due to the respiratory burdens of the coronavirus.

COPD patients with unnoticed OSA are at a greater risk of hospital readmission and even all-cause mortality.

Al Rizzo, MD, of the American Lung Association, discusses some of the biggest challenges and questions raised on lung health during the coronavirus pandemic.

New findings show asthmatic children in a highly-polluted region improved in small airway function when their bedroom air was filtered.

New pivotal phase 3 findings support an upcoming sBLA for the IL4 and IL13-targeting agent.

A Vancouver-based cohort shows association between increased infancy antibiotic use, gut microbiome manipulation, and asthma development by age 5.

Discussing an editorial in the Journal of Clinical Endocrinology & Metabolism with journal editor in chief Paul Stewart, MD.

Allergic rhinitis is the most frequent atopic coexisting disease in the LIBERTY ASTHMA VENTURE study.

A pediatric version of the ASTHMAXcel mobile application will include games.

Results of a study show the efficacy of an artificial intelligence chatbot for patients with asthma and pregnant women.

About 1 in every 20 adult Americans now reguarly uses vaping and e-cigarette products.

A new asthma study will leverage real-time data in the next 10 years.

Technology, data, and community partnerships can help improve the overall health of patients with chronic health conditions.

Doctors of all fields, including pulmonologists, are coming together to collaborate on research regarding the ongoing threat of the coronavirus.

Telehealth tools can identify someone whose symptoms are worsening and connect them to a medical professional.

Roy Schoenberg, MD, MPH, discusses the populations that can most benefit from using telehealth tools and Medicare reimbursement obstacles.

The label update comes after findings have repeatedly shown an associated risk of neuropsychiatric events.

The FDA announced the first approval of ProAir HFA—1 of the most popular inhalers in the US market.

A new guidance breaks ground as the first of its kind to assist physicians in screening for, and treating, vaping-associated respiratory disease syndrome.

New follow-up data shows older patients with COPD characterized by high blood eosinophil counts may benefit from the biologic.

New VDAART follow-up findings show at-risk children are not safer from asthma or recurrent wheeze when their mother takes prenatal vitamin D.

An analysis of the MESA study is shedding light on the potential association between having persistent asthma and developing atrial fibrillation.